Honkai: Star Rail Second Closed Beta Trailer - Your Choice | Honkai: Star Rail

Second Closed Beta Sign-Up: https://hoyo.link/5banWHB6

The Destruction has no choice but to wipe out all the stains of the tainted universe.
The Preservation has no choice but to build walls to protect worlds where life still endures.
But you still have a choice — reach the ending of the story in your own way!

※※※ Event With Rewards ※※※
Trailblazers, will you choose Destruction or Preservation? What leads to this decision?
Complete the Second Closed Beta sign-up and leave a comment and your HoYoverse Account ID below this video before 2022/5/4 23:59 (UTC+8) for a chance to win rewards!
※ Please log in to your account at https://account.hoyoverse.com/ and go to "Account Information" to check your "User ID".

■ Event Rewards
Honkai: Star Rail Second Closed Beta Access — 100 Trailblazers

■ Attention
1. The list of winners will be announced on 2022/05/19 (UTC+8) in the comments section below this video.
2. Beta access will only be issued to the HoYoverse Account ID provided in the respective comment, and cannot be transferred to other accounts. Trailblazers who didn't provide the correct HoYoverse Account ID or who didn't complete the Second Closed Beta sign-up on time will be considered to have forfeited their beta access. Access will not be re-issued.
3. Matters not covered in the rules of this event are still applicable as outlined by the Honkai: Star Rail game product Terms of Service and Privacy Policy agreed to by the Trailblazers.

Follow our official social media to get the latest information.
Official Website: https://hsr.hoyoverse.com/en-us
HoYoLAB: https://www.hoyolab.com/home
Official Facebook: https://www.facebook.com/HonkaiStarRail/
Official Twitter: https://twitter.com/honkaistarrail
Official Discord: https://discord.gg/honkaistarrail
Official Instagram: https://www.instagram.com/honkaistarrail/

#HonkaiStarRail

Honkai: Star Rail Second Closed Beta Trailer - Your Choice | Honkai: Star Rail


#honkaistarrail

Post a Comment

0 Comments